INTERACTIVE BREAKOUT DISCUSSIONS


Interactive Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. For this in-person event, the facilitator will lead from the front of the room while attendees remain seated to promote social distancing. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing.

MONDAY, FEBRUARY 21

9:45 am Interactive Discussions

Topics:

Genomics and Molecular Phenotyping for Precision Health
Moderator: Erica F. Sanford Kobayashi, MD, Assistant Professor, Rady Children's Hospital San Diego

Elevating the Value of At-Home Testing: What Can We Do Now?
Moderator: Hoi-Ying Elsie Yu, PhD, System and Core Laboratory Director, Chemistry, Toxicology and Point-of-Care Testing, Geisinger Health System

Advances in Liquid Biopsy for Early Detection and Screening
Moderator: Minetta C. Liu, MD, Professor & Research Chair, Oncology & Consultant, Lab Medicine & Pathology, Mayo Clinic & Foundation

Assay Development and Technology Advances for Spatial Multi-Omic Analysis
Moderator: Daniel T. Chiu, PhD, A. Bruce Montgomery Professor of Chemistry; Endowed Professor in Analytical Chemistry; Professor of Bioengineering, University of Washington

WEDNESDAY, FEBRUARY 23

3:35 pm Interactive Discussions

Topics:

The Changing Landscape of Diagnostics Reimbursement and Market Access in the Post-Pandemic Era
Moderator: Lon Castle, MD, CMO, Molecular Genetics & Personalized Medicine, eviCore healthcare

Innovation and Future Directions in Infectious Disease Diagnostics: COVID-19 and Beyond
Moderator: Christopher W. Woods, MD, MPH, Professor, Medicine, Global Health & Pathology, Duke University

Biomarker-Enabled Precision Medicine: Status Update and Future Opportunities
Sam Hanash, MD, PhD, Director, Red & Charline McCombs Institute; Evelyn & Sol Rubenstein Distinguished Chair, Cancer Prevention; Professor, Clinical Cancer Prevention-Research, Translational Molecular Pathology, University of Texas MD Anderson Cancer Center

 


Register Now
March 11-12, 2025

Artificial Intelligence in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology and Single-Cell Multiomics

March 12-13, 2025

Diagnostics Market Access

Precision Medicine Beyond Oncology

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Clinical Biomarkers & Companion Diagnostics